CELEX: 62019TA0853
Language: en
Date: 2021-03-17 00:00:00
Title: Case T-853/19: Judgment of the General Court of 17 March 2021 — Tehrani v EUIPO — Blue Genes (Earnest Sewn) (EU trade mark — Invalidity proceedings — EU word mark Earnest Sewn — Declaration of invalidity — Absolute ground for refusal — Bad faith — Article 52(1)(b) of Regulation (EC) No 207/2009 (now Article 59(1)(b) of Regulation (EU) 2017/1001))

31.5.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 206/22
            
         
      Judgment of the General Court of 17 March 2021 — Tehrani v EUIPO — Blue Genes (Earnest Sewn)
      (Case T-853/19) (1)
      
      (EU trade mark - Invalidity proceedings - EU word mark Earnest Sewn - Declaration of invalidity - Absolute ground for refusal - Bad faith - Article 52(1)(b) of Regulation (EC) No 207/2009 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
      (2021/C 206/27)
      Language of the case: English
      
         Parties
      
      
         Applicant: Reza Hossein Khan Tehrani (Nordhorn, Germany) (represented by: D. Wiedemann, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: D. Hanf and V. Ruzek, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO: Blue Genes, Inc. (Gardena, California, United States)
      
         Re:
      
      Action brought against the decision of the Fifth Board of Appeal of EUIPO of 4 October 2019 (Case R 531/2018-5), relating to invalidity proceedings between Blue Genes and Mr Tehrani.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Mr Reza Hossein Khan Tehrani to pay the costs.
               
            
         (1)  OJ C 54, 17.2.2020.